|
|
||||||||
1 Institut National de la
Santé et de la Recherche Médicale U 300, Muscle
disuse induces substantial alterations in the highly plastic skeletal
muscle tissues, which occur especially in antigravity slow muscles. We
differentially screened a muscle cDNA array to identify modifications
in gene profile expression induced in slow rat soleus muscle
mechanically unloaded by hindlimb suspension as a model for muscle
disuse. This study focused on muscle creatine kinase mRNA and protein
and glyceraldehyde-3-phosphate dehydrogenase mRNA, which were found to
be upregulated in unweighted muscles. These upregulations were analyzed
over a 4-wk time course of hindlimb suspension and compared with
variations in myosin heavy chain (MHC) isoforms while specifically
focusing on type IIx MHC mRNA and protein. The two metabolic marker
upregulations clearly preceded IIx MHC contractile protein
upregulation. Muscle creatine kinase upregulation was shown to be an
excellent, and the earliest, marker of muscle disuse at mRNA and
protein levels.
gene regulation; muscle atrophy
SKELETAL MUSCLES ADAPT very rapidly to disuse by
undergoing atrophy, a major phenotypic consequence. This phenomenon is
one of the many aspects of widely documented muscle plasticity.
Nonpathological quantitative and qualitative changes in skeletal muscle
tissue are associated with pre- and postnatal development,
regeneration, hormonal environment, aging, exercise, training, and
disuse (for review see Ref. 30). For most muscles, these different
factors control the size of muscle fibers and their fast- or
slow-twitch properties, which, in turn, determine their mechanical
capacities for generating short, but intense, or weaker, but longer,
contractions. Muscle disuse is a very common situation that occurs each
time a muscle remains inactive for an extended period, e.g., during limb immobilization or bed rest; it also occurs in zero gravity situations encountered during spaceflights. In the case of responses to
disuse, many quantitative modifications have now been described and
important studies have also revealed that induced atrophy is a highly
regulated process that does not completely impair muscular functional
activity and generally allows reverse evolution back to a nonatrophied
state (16).
Different animal models concerning muscle disuse have been studied,
including unweighting by hindlimb suspension (HS), physical immobilization, and exposure to microgravity environments. In these
situations, a spectacular loss of muscle mass can be obtained, especially in postural predominantly slow-twitch muscles, which normally counteract gravity (28). This atrophy is due mainly to a
decrease in fiber size, correlated with a decrease in myofiber protein
content but usually not a decrease in the fiber population (5). Protein
synthesis is actually decreased and protein degradation increased (39).
In addition, mechanical properties of atrophied soleus muscles are
modified. As can be expected, they lose strength but gain some
fast-twitch features, with an increase in maximum unloaded shortening
velocity (Vmax), higher myosin
adenosinetriphosphatase activity, and faster contraction/relaxation
times (15, 23). However, Vmax
stays significantly lower than in fast-twitch gastrocnemius control
muscle (19). Adaptation thus results in fibers becoming smaller but
also closer to a fast-twitch type. This is supported by shifts from
various slow-twitch contractile protein isoforms toward fast-twitch
isoforms (11, 15, 24). This was clearly demonstrated for myosin heavy
chains (MHC), with a decrease in the proportion of slow-type I MHC (10)
and a corresponding increase in fast-type II MHC isoforms (2). In rat
slow-twitch soleus muscle, a fast isoform (IIx MHC) that is not
normally significantly expressed in this muscle (3) appears (29, 36)
with an adenosinetriphosphatase activity midway between that of the two
other fast-type isoforms, IIa and IIb MHC (33). MHC expression changes
have been detected at the protein and RNA levels and give rise to many
more hybrid fibers coexpressing different MHC isoforms than in
nonatrophied soleus muscles. These contractile protein modifications
occur concomitantly with increases in the ratios of glycolytic to
oxidative enzyme activities (18, 24). This reduces the oxidative
capacity of skeletal muscle, with a marked increase in the glycolytic
metabolism. Other gene expression modulations were found to be
associated with muscle atrophy, induced by HS or physical
immobilization. Cytochrome-c mRNA transcripts are
downregulated (5), whereas there is upregulation of muscle-specific
kinase MuSK mRNA transcripts and proteins (41), dihydropyridine
receptor mRNA transcripts (21), and the fast isoform of the
sarcoplasmic reticulum calcium pump mRNA transcripts and proteins (35).
However, the cellular and molecular mechanisms underlying these changes
are far from being clearly understood. With the aim of developing a
general analysis of molecular mechanisms triggered by muscle disuse and
inducing muscle atrophy, we decided to investigate genes up- or
downregulated in postural slow-twitch soleus muscles in the HS rat
model. In this model, hindlimb muscles undergo hypodynamia (decreased
mechanical loading) and hypokinesia (decreased motor activity), whereas
the hindlimbs can move freely. The basic hypothesis was that disuse
modifies or creates cascades of cellular signals and some of them could
interfere with the transcription levels of certain genes.
Identification of such genes will provide molecular tools for analyzing
the muscular atrophy process. Different techniques are now available to
characterize changes in gene profile expression. The approach used here
involved quantitative differential screening of a muscle cDNA library
arrayed on high-density filters based on comparison of hybridization
signals given by labeled total cDNA pools synthesized from HS versus
control soleus muscles. The intensity of signals for a given cDNA clone
was determined by its expression level in the cDNA pool probe and
therefore by the expression level of the corresponding mRNA in the
original tissue (27). To our knowledge, this is the first time this
approach has been used to study changes induced by muscle disuse. As a first step, an already available human muscle cDNA array was used to
test the feasibility of this approach (1). Three genes were found to be
upregulated in HS rat soleus and one gene was found to be
downregulated. Two of these four genes were already known, i.e., muscle
creatine kinase (M-CK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). They were the target of the present study at the
RNA and encoded protein levels, with particular focus on changes
related to HS duration in comparison to MHC isoform changes.
Animals and tissues. After 4 days of
acclimatization to the animal room, female Sprague-Dawley rats weighing
200- 220 g were randomly divided into two groups
(n = 9) for each time point, HS and
control weight-bearing groups. The HS groups were submitted to 2, 4, 8, 21, or 28 days of HS, using an apparatus similar to that described by
Morey (25). All animals were maintained on a standard diet with water
ad libitum. They were housed in a room with a regulated temperature
(22°C) and 12:12-h light-dark cycle. At the end of the experiments,
HS and age-matched control animals were euthanized with a lethal dose
of pentobarbital sodium administered intraperitoneally. Right and left
soleus muscles were excised rapidly and immediately frozen in liquid
nitrogen. All samples were stored at RNA preparation. Isolation of total
cellular RNA from 1- to 2-g pools of 18 soleus muscles was performed
using the acid guanidinium thiocyanate-phenol-chloroform method, as
described by Chomczynski and Sacchi (12). Total RNA concentrations and
purities were assessed by measuring absorbance at 260 and 280 nm and by
agarose gel electrophoresis.
Poly(A)+ RNAs were purified on
oligo(dT) bound to magnetic spheres (PolyAtract mRNA Isolation Systems;
Promega) according to manufacturer's instructions. Their qualities
were assayed by Northern blot analysis probed with Differential screening procedures.
Fifty to one hundred nanograms of 1339 PCR-amplified and both end
sequenced cDNAs from a human skeletal muscle were spotted onto
high-density nylon filters (8 × 12 cm; Hybond
N+, Amersham) as described in
Piétu et al. (31). Two duplicate filters were probed with
33P-labeled single-strand cDNAs
derived from HS rat soleus muscles, and two other duplicate filters
were hybridized in identical conditions with equivalent probes derived
from control soleus muscles.
33P-labeled single-strand cDNA
probes (1 × 108 to 5 × 108 dpm/µg) were prepared from
500 ng of poly(A)+ RNA extracted
from soleus muscle pools (n = 18 muscles) according to Sambrook et al. (32), in
the presence of 1 µg of a poly(dA) 80 mer (27), with SuperScriptII
reverse transcriptase (GIBCO BRL). Unincorporated radioactive
nucleotides were removed on a NucTrap probe purification column
(Stratagene). Filters were hybridized overnight with 5 × 106 cpm/ml of probe in the
presence of 37% formamide at 42°C, washed 3 × 15 min with
1× SSC (1× SSC is 0.15 M NaCl and 0.015 M sodium citrate,
pH 7.0), 0.1% SDS at room temperature and scanned on a PhosphorImager
imaging plate system (Molecular Dynamics, Sunnyvale, CA) for
quantitative analysis of hybridization signal intensities with the
X-dots Reader software (Cose, Le Bourget, France). Statistical analyses
of the results were performed as previously described (31), and
differentially expressed cDNAs were selected. Automatic DNA sequencing
of the selected clones was performed by Genome Express (Grenoble,
France), and sequence data were compared with public nucleotide and
protein databases using BLAST and FASTA programs from the National
Center for Biotechnology Information WWW server.
Northern blots. About 40 µg of total
RNA prepared from soleus muscle pools (n = 18) was size fractionated in
denaturing 1% agarose gel in the presence of ethidium bromide (25 µg/ml), transferred to nylon membranes, as described by the supplier
(ICN), and fixed by ultraviolet irradiation. The specific sequence cDNA
probes used in this study were human M-CK partial cDNA corresponding to
nucleotides 692-1086 (94% homology with rat M-CK), human GAPDH 1-kb partial cDNA corresponding to nucleotides 195-1180 (87%
homology with rat GAPDH), rat IIx MHC cDNA (generous gift from Dr.
Stephano Schiaffino) derived from the 3'-untranslated region,
mouse MyoD complete cDNA (kindly provided by Dr. C. Pinset and Dr. D. Montarras), which was 84% homologous to rat MyoD, and a
mammal-specific 18S rRNA oligonucleotide
(5'-GCACGGCGACTACCATCGAA-3'). Generated cDNA probes were
[ CK analysis. According to the method
described by Brosnan et al. (8), whole tissue extracts were
prepared by homogenizing soleus muscle pools
(n = 18) for 20 s in a 1:10 dilution
of tissue to buffer containing 26 mM Tris, 0.3 M sucrose, 1% NP-40,
and 20 mM Electrophoretic separation of MHC
isoforms. Electrophoretic separation of MHC isoforms
from soleus muscle pools (n = 18) was performed using the methods described by Talmadge and Roy
(37). Four different MHC isoforms were identified by this procedure (fast-type IIa, fast-type IIx, fast-type IIb, and slow-type I MHC
isoforms). Gels were silver stained as described by Bio-Rad (Silver
Stain Plus; Bio-Rad) and quantification of the isomyosin bands
performed with an Agfa optical densitometer using Phoretix software
(Biocom). The data were expressed as a percentage of total MHC
isoforms, and the SE of these measurements was estimated at 1-2%
(n = 4 or 5).
Statistical analyses. The results are
expressed as means with SE of at least triplicate measurements. The
Student's t-test was used to evaluate
differences in means, with significance set at
P < 0.05.
Progress of atrophy during 4 wk of HS.
The effect of muscle disuse was studied in the HS rat soleus muscle
model. The progress of atrophy was evaluated by comparing the mass of
soleus muscles (n = 18) after 2, 4, 8, 21, and 28 days of suspension with age-matched control muscles (Fig.
1). Control soleus mass was 120 ± 7 mg
(n = 45). The loss of mass appeared
very rapidly: soleus muscles weighed only 80% of controls after only 2 days of suspension. Atrophy continued to progress further, but at a
slower pace, and reached ~50% of the control at 28 days. Protein and
RNA contents were compared with control and HS soleus muscle wet
weights at each time point (Table 1). No
significant differences were found, indicating no effect of disuse on
total protein and RNA contents relative to soleus muscle wet weight.
![]()
ABSTRACT
Top
Abstract
Introduction
Experimental procedures
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Experimental procedures
Results
Discussion
References
![]()
EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Experimental procedures
Results
Discussion
References
80°C until further
analyses, which were all performed on pools of 18 soleus muscles from
each rat group to eliminate any individual variations. In each pool,
all entire soleus muscles were used for RNA preparations to extract
sufficient quantities of RNA, and equal small middle portions from all
soleus muscles were used for protein extractions.
-actin.
-32P]dCTP labeled
by random priming (DNA labeling beads, Pharmacia). Oligonucleotides
were labeled at the 5'-end with T4 polynucleotide kinase and
[
-32P]ATP. Labeled
probes were purified through G50 spin columns. Hybridizations were
carried out overnight at 42°C in 25% formamide, 5× sodium
chloride-sodium phosphate-EDTA (SSPE), 5× Denhardt's solution,
100 µg/ml salmon sperm DNA. Membranes were washed in 0.1× SSPE,
0.2% SDS, for 30 min at 50°C and exposed to phosphorus screens
scanned with the PCBas program (Fujix). Membrane stripping was
performed in 0.1% SDS at 80°C. mRNA expression levels were standardized according to 18S rRNA hybridization signals; the error
margin for the HS-to-control signal quantification ratios could be
estimated at 17% after measuring eight independent Northern blots
prepared with different RNA preparations and hybridized with M-CK cDNA probes.
-mercaptoethanol, pH 8.4. After centrifugation,
supernatants were diluted to 800 µl with extraction buffer and 1 µl
was loaded onto 1% agarose gel (Ciba-Corning). Electrophoresis was
performed at 120 V for 20 min at 4°C. CK activity was visualized
according to the CK Isoenzyme System procedure (Ciba Corning) and the
enzymatic reaction product (NADPH) was directly visualized with
ultraviolet light. To quantitate CK activity, regions on the gel with
detectable levels of NADPH were excised and incubated for 2 h in 1 ml
of 100 mM Tris at 4°C. Absorbance was measured at 340 nm. CK
activity was linear over the tissue extract concentration range used.
The results were standardized by muscle extract protein concentrations, as determined by the method of Bradford (6).
![]()
RESULTS
Top
Abstract
Introduction
Experimental procedures
Results
Discussion
References

View larger version (12K):
[in a new window]
Fig. 1.
Time course of atrophy. Soleus muscles from female Sprague-Dawley rats
were sampled after 0, 2, 4, 8, 21, and 28 days of hindlimb suspension
(HS), which was performed according to Morey's procedure (25). Data
are expressed as HS soleus muscle mass percentages of age-matched
control values and represent means of 18 values at each time point with
±6% SD. Differences from control were significant for all values
reported (P < 0.05). Before the
beginning of HS, at day
0, the soleus mass was 120 ± 7 mg.
Table 1.
Total RNA and protein content relative to soleus muscle wet weight
Progress of MHC isoforms during 4 wk of
HS. The atrophy pattern was compared with the
expression of MHC isoforms in the present study, because their relative
contents are modified in various muscle atrophy models (36). MHC
isoforms from pools of soleus muscles
(n =18) were separated by SDS-PAGE
according to Talmadge and Roy (37) and quantified by densitometer
scanning (Fig. 2). Two isoforms were
modified within the first 2 days of suspension; the I MHC percentage of
total MHC decreased and the IIx MHC isoform appeared specifically in HS
soleus muscle, although it was absent in the control. This decrease in
I MHC and increase in IIx MHC continued at a slower pace thereafter
until the 28th day of suspension. After the 8th day, we observed two
further modifications, with a slight decrease in the amount of IIa MHC
and the appearance of IIb MHC. The overall pattern noted with our
experimental model confirmed the expected slow-to-fast-twitch fiber
switch and showed that the full range of known MHC isoforms, even the
fast-twitch glycolytic type IIb MHC, can be expressed in slow-twitch
soleus muscle (4) if the mechanical unloading lasts >8 days. Each MHC
isoform exhibited its own expression profile throughout the 28 days of
HS, and the most quantitatively marked modification concerned the
appearance of IIx MHC, which continuously progressed and finally
reached 20% of total MHC.
|
Search for genes up- or downregulated in soleus muscle
after 4 wk of HS. To gain a better understanding of the
molecular mechanisms involved in disuse muscular atrophy, differential
screening of a muscle cDNA library was carried out with
33P-labeled total cDNA pools
prepared from rat soleus muscle pools (n = 18) after 28 days of HS in
comparison with the control counterpart. As a first step in this
strategy, the library was a subset of 1,339 end-sequenced PCR inserts
of a human muscle cDNA library, organized on one high-density filter
(31). About one-half of the clones gave a detectable signal with the
rat probes. Twenty cDNA clones showed a differential hybridization
signal between HS rat soleus probes and control probes. HS and control
soleus Northern blots were probed with these 20 cDNA clones, and
finally four of them exhibited significant and reproducible
differential expression between three different 28-day HS and
control RNAs (Fig. 3). Three cDNA clones
hybridized to upregulated mRNA transcripts in HS soleus muscle; the
sequences of two of them were already known: M-CK, nucleotides
692-1086, and GAPDH, nucleotides 195-1180; the third one
(b-b8e08) had a sequence that did not match any others in the available
public data banks. One cDNA clone (b-10g06) was downregulated in HS
soleus muscle, and sequence analysis showed that it also corresponded
to a new gene. The present study focused on the two known genes (M-CK
and GAPDH) with regard to their importance for muscle energetic
metabolism.
|
Comparative progression of M-CK, GAPDH, and IIx MHC
mRNA upregulations during 4 wk of HS. Quantitative
Northern blot analyses performed with total RNAs prepared from at least
three different soleus muscle pools were carried out at 2, 4, 8, 21, and 28 days of HS to assess the relative expression of M-CK and GAPDH
by comparison with controls. Because the IIx MHC protein was found
above (Fig. 2) to be an early and specific marker of soleus muscle
disuse consequences, its mRNA expression was also measured on the same Northern blots (Fig. 4). Hybridization
signals were quantified on phosphorus screens and standardized
according to the 18S ribosomal RNA signal. The three mRNA expressions
measured showed upregulation as early as the 2nd day of HS. M-CK mRNA
showed the earliest upregulation, which reached 173 ± 40% (70% of
its peak time point) after 2 days of HS treatment, although, at the
same time, loss of mass was only about one-half its peak time point
value. M-CK upregulation peaked at ~4 days of HS and then remained
stable until the 28th day. This maximum value (referred as 100% in
Fig. 4) represented an increase in mRNA expression of 248 ± 42% by
comparison with age-matched controls. GAPDH mRNA upregulation showed a
comparable pattern, but only peaked at 8 days, which represented 255 ± 43% upregulation (100% of the peak time point). Finally, IIx
MHC mRNAs were undetectable before HS, and their expression increased
the slowest to reach a maximum around
day
21 of HS. In fact this slower increase
of IIx MHC mRNAs represented a very important quantitative increase,
because the amount detected at day
28 of HS represented an increase of
790% (100% of the peak time point) of the amount detected at
day 2 of HS. The progression of upregulation of M-CK mRNAs and, to a lesser
extent, GAPDH mRNAs, preceded soleus atrophy measured in terms of a
loss of mass. In contrast, there was a delay in the appearance of IIx
MHC mRNAs.
|
Comparative progression of MM-CK and IIx MHC protein
upregulation during 4 wk of HS. To test a potential
functional significance of the earliest mRNA upregulation, i.e., M-CK
mRNA, we assayed the amounts of CK protein isoforms during 4 wk of HS
(Fig.
5A) in
comparison with the appearance of the IIx MHC protein isoform (Fig. 2).
CK is assembled in three dimeric and one octameric structure (13, 34):
MM (muscle type), BB (brain type), MB (muscle/brain hybrid type), and
mitochondrial type, respectively. CK activity was detected in muscle
extracts analyzed on agarose gels (8). As expected, only the MM-CK
isoprotein was seen in muscle extracts. Figure
5B shows the comparative variations in
MM-CK and IIx MHC proteins expressed as percentages of the peak time
points. Three independent experiments were quantified for each time
point. The upregulation noted at the mRNA level was basically found at
both protein levels but with interesting differences. MM-CK protein upregulation peaked at day
21 with a progression pattern
identical to that of soleus loss of mass, with a fast increase until
day 4 followed by a slower pattern. This therefore represented a delayed response compared with the early upregulation of M-CK mRNA. This maximum upregulation of MM-CK protein (100% of the peak time point) was quantified as a 295 ± 22% (n = 3) increase compared with the control value. IIx MHC protein
upregulation followed with only a slight delay in mRNA upregulation,
thus occurring later than the loss of mass. However, the amount of this
protein increased by 520% between day
2 and
day
28 of HS, this latter time point representing 100% of the peak time point.
|
M-CK upregulation is not correlated with a
modification in MyoD expression. M-CK transcription is
regulated by several transcription factors (26). One of them is the
myogenic factor MyoD that binds to the E box present in the M-CK gene
promoter. With regard to this role of MyoD and its key role in
myogenesis, we wondered whether or not its expression would be modified
during the 4 wk of HS. The same Northern blots used to analyze the
expression of M-CK, GAPDH, and IIx MHC were probed with a mouse MyoD
probe (Fig. 6). No differential expression
was found at any time tested, indicating that upregulation of M-CK was
controlled by other factors than a MyoD transcriptional modification
between days
2 and
28 of HS.
|
| |
DISCUSSION |
|---|
|
|
|---|
Upregulation of M-CK and GAPDH by HS. Altered expression of very few genes other than myosin isoforms has been found to date, i.e., dihydropiridine receptor (21) and sarcoplasmic reticulum calcium pump (35), in the muscle disuse model involving soleus muscles from HS rats. In this context, we started a more systematic search of other up- or downregulated genes by quantitative differential screening of a muscle cDNA array to investigate transcriptional gene modulations associated with skeletal muscle adaptations to disuse. The results presented here focused on two upregulated genes, i.e., M-CK and GAPDH. Variations in the upregulations of these two mRNAs were compared with the progression of soleus muscle atrophy and to IIx MHC mRNA expression, because MHC and especially the IIx MHC isoform are major biochemical markers previously described for modifications induced by mechanical unloading. This comparison was performed at different time points over a 4-wk period of hindlimb unweighting. Upregulation of the two genes encoding metabolic proteins (MM-CK and GAPDH) started clearly before upregulation of the gene encoding the contractile IIx MHC protein. M-CK upregulation was found to be the earliest marker at both the mRNA and protein levels. Moreover, MM-CK protein upregulation exactly paralleled the progression of atrophy, therefore constituting an excellent marker for skeletal muscle adaptations to disuse. These data demonstrate that muscle loading necessary for weight support can modulate the expression of M-CK and GAPDH genes.
cDNA array differential screening strategy. The present findings for four genes whose expression was modified in HS soleus muscles confirmed our working hypothesis concerning variations in gene expression profiles associated with skeletal muscle disuse and confirmed the utility of identifying such genes to investigate molecular aspects of mechanisms induced by muscle disuse leading to muscle atrophy. This work demonstrates the feasibility of the cDNA array quantitative differential screening approach for finding up- or downregulated genes during the muscular atrophy process. Note that finally only four cDNAs with differential expression could be measured by Northern blot analysis. The main factor to explain this low yield is that we screened human muscle cDNAs with rat muscle cDNAs probes. This explains why only about one-half of the arrayed cDNAs gave a hybridization signal, although sequences occurring in very low abundance were also expected to give no detectable hybridization signals. In addition, because heterologous cDNA probes were used, filter hybridizations and washes could not be carried out under the highest stringency conditions, which is a major source of false-positive signals (20). Another technical limitation was that the screened cDNA library contained only 1,339 cDNA clones without systematic equalization of their expression frequency in muscle. However, abundant clones such as myosin cDNAs had been removed from this collection to avoid redundancy, which explained why no MHC isoform cDNA was found in the screening. Therefore the low abundant expressed cDNAs were under represented in the array. Further optimizations of the differential screening technology should include the use of rat (instead of human) muscle cDNA arrays, preferably after normalization and subtraction, to gain access to a more exhaustive cDNA population that includes rare sequences.
Importance for slow-to-fast-twitch transition. Our HS model was validated by the time course progression of the different MHC isoform proportions, which closely agreed with previous results (4, 16, 38), showing an increase in the percentages of fast MHC isoforms. In addition, this was documented in the present study with the four MHC isoforms at several time points throughout 4 wk of HS. The early decrease in the slow-twitch I MHC was compensated by neoexpression of the fast-twitch intermediate IIx MHC isoform. After 8 days of HS, MHC isoforms expressed in most glycolytic muscle fibers were amplified by a decrease in fast-twitch IIa MHC, which are expressed in fast oxidative-glycolytic fibers, and neoexpression of fast-twitch IIb MHC, which are expressed in pure fast glycolytic fibers, as already reported by Fauteck and Kandarian (17). MHC isoprotein content determines the mechanical characteristics of muscle contraction. The present results indicated that the response of an antigravity muscle such as the soleus to unloading by hindlimb unweighting was a continuously changing process that was still not stabilized after 4 wk, as indicated by the nonplateau curves for the MHC isoform percentages (Fig. 2).
Biochemical modifications occurring in unweighted soleus muscles have been mainly documented for MHC protein isoforms, which determine the fast- or slow-twitch phenotype by their adenosinetriphosphatase activities. However, it has not yet been shown whether the entire muscle fiber contractile protein content, which can also be expressed with slow or fast isoforms, is actually involved in such phenotypic changes. In addition, this slow-to-fast shift is limited; soleus muscles gain some fast-twitch-type mechanical features (24), but they never become pure fast-twitch-type muscles, which is related to the heterogeneity noted in the muscle fiber population. Upregulation of M-CK and GAPDH provides new information concerning the extent of transformation of soleus muscles to a faster type. These metabolic enzymes do not have slow and fast isoforms but they are highly expressed in muscles possessing high glycolytic potentials and low resistance to fatigue (42). Upregulation of their mRNA transcripts and upregulation of MM-CK proteins show that they are components involved in fast-type transformation of soleus muscles, which is in agreement with the key role of these two enzymes in muscle energetic metabolism. Although many slow fibers are induced to coexpress fast and slow myosin isoforms (28, 38), this is not the case for all of them. No histological results were obtained in the present study, and we thus cannot correlate the upregulation of M-CK and GAPDH with different types of atrophied soleus muscle fibers. However, it is rational to speculate that hybrid fibers coexpressing both slow and fast myosins represent the main site where these upregulations preferentially take place. In this case, such upregulations in these fibers would be much higher than the average upregulations measured with RNA extracted from all soleus fibers, including the remaining slow-twitch type. In addition, regarding the time course described in our results, M-CK then GAPDH were part of the first genes upregulated in the transformation process toward a faster phenotype. The fast-twitch-type features of crucial metabolic enzymes such as M-CK and GAPDH were turned on before contractile proteins such as IIx MHC, suggesting that metabolic adaptations precede structural adaptations. This very early adaptation of metabolic components has also been observed with the dramatic upregulation of the sarcoplasmic reticulum calcium pump (35) and with upregulation of the dihydropyridine receptor (21).
Origin of M-CK and GAPDH upregulation: importance for
muscle disuse. The cause of the observed M-CK and GAPDH
mRNA transcript upregulation could have a pre- or posttranscriptional
origin. We investigated the involvement of one mRNA transcription
factor, i.e., MyoD, but the results were negative. This observation was consistent with a recent study (14) based on hindlimb immobilization, an HS close model for muscle disuse. No alterations were found for MyoD
and myogenin mRNAs, which both encode components with a M-CK E box
binding activity (7). However, our results do not rule out possible
modifications in the binding activities of MyoD protein, as
demonstrated for the myogenin-Jun-D complex on the M-CK enhancer, in a
muscle wasting situation (9). The main arguments in favor of
pretranscriptional regulation are 1) this is the most common mechanism of transcript up- or downregulation and 2) Tsika et al. (40) have
recently delineated 5'-regulatory regions responsible for
downregulation of the M-CK gene induced by mechanical overload in
fast-twitch rat plantaris muscle, which closely parallels the
mechanical unloading situation studied in the present work. It would be
particularly useful to study the roles of these elements and their
binding transacting factors in our hindlimb unweighting model, to
determine the signals controlling the regulation of M-CK by unloading.
The same laboratory very recently delimited a 600-bp region in the
-MHC promoter containing sequences sufficient to direct decreased
transcription of
-MHC in HS mouse soleus muscles (22). This other
indication of mechanical loading as a signal for gene transcriptional
regulation opens the way for new challenging investigations that could
explain how these controls are coordinated to induce phenotypical
modifications in skeletal muscles. It will be of particular interest to
investigate these regulatory M-CK gene
cis-acting elements that may be
directly responsive to mechanical load or targets for proto-oncogenes
such as Jun-D, which are known to be the very first
signals modified in many cellular stresses. Their existence suggests
that, in addition to being a marker of events induced by muscle disuse,
M-CK is one of the upstream causes of these events. In fact, the very early M-CK upregulation in our HS model and its key role in energy maintenance supply in high energy demanding skeletal muscle tissues indicate that M-CK is a crucial component for determining the muscle phenotype.
Perspectives
Our findings further demonstrate that skeletal muscles undergo active adaptation to disuse. Considering the importance of understanding this aspect of muscle plasticity and the interest of determining therapeutic targets for controlling muscle atrophy, further investigations are required especially to specify the exact location of M-CK upregulation in the cascade of molecular events triggered by muscle disuse. One possible direction mentioned above concerns the analysis of transduction signals that link mechanical load and regulation of M-CK gene expression. A second direction would be to study how inactivation of the M-CK gene could be compensated for in HS transgenic animals. Another broader direction is to continue identifying more genes with deregulated expression in muscle disuse and to try to determine whether they interfere with M-CK-related mechanisms or if they belong to other independent pathways for controlling muscle phenotype. This will ultimately provide new insight into molecular mechanisms involved in fine tuning of genome expression in response to common muscle physiology situations that might be important for other tissues.| |
ACKNOWLEDGEMENTS |
|---|
We are very grateful to Dr. Stephano Schiaffino for providing the IIx MHC cDNA probe, to Dr. Guy Ixart for access to the Université Montpellier II animal facilities for hindlimb suspension experiments, and to Angèle Chopard for help in the densitometry scanning. We also thank Dr. Françoise Pons for very helpful discussions and Dr. Andrei Tkatchenko for comments on the manuscript.
| |
FOOTNOTES |
|---|
N. Cros has a fellowship from the Association Française contre les Myopathies, which supported this work with the Institut National de la Santé Et de la Recherche Médicale.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: C. A. Dechesne, INSERM U 300, Faculté de Pharmacie, Avenue Charles Flahault, 34060 Montpellier cedex 01, France.
Received 25 February 1998; accepted in final form 28 September 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Auffray, C.,
G. Behar,
F. Bois,
C. Bouchier,
C. D. Silva,
M. D. Devignes,
S. Duprat,
R. Houlgatte,
M. N. Jumeau,
B. Lamy,
F. Lorenzo,
H. Mitchell,
R. Mariage-Samson,
G. Pietu,
Y. Pouliot,
C. S. Kabaktchis,
and
A. Tessier.
IMAGE: intégration au niveau moléculaire de l'analyse du génome humain et de son expression.
C. R. Acad. Sci.
318:
263-272,
1995.
2.
Baldwin, K. M.
Effect of spaceflight on the functional, biochemical, and metabolic properties of skeletal muscle.
Med. Sci. Sports Exerc.
28:
983-987,
1996[Medline].
3.
Bär, A.,
and
D. Pette.
Three fast myosin heavy chains in adult rat skeletal muscle.
FEBS Lett.
235:
153-155,
1988[Medline].
4.
Bigard, A. X.,
D. Merino,
F. Lienhard,
and
B. Serrurier.
Quantitative assessment of degenerative changes in soleus muscle after hindlimb suspension and recovery.
Eur. J. Appl. Physiol.
75:
380-387,
1997.
5.
Booth, F. W.,
and
R. K. Kirby.
Changes in skeletal muscle gene expression consequent to altered weight bearing.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R329-R332,
1992
6.
Bradford, M. M.
A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding.
Anal. Biochem.
72:
248-254,
1976[Medline].
7.
Brennan, T. J.,
and
E. N. Olson.
Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization.
Genes Dev.
4:
582-595,
1990
8.
Brosnan, M. J.,
S. P. Raman,
L. Chen,
and
A. P. Koretsky.
Altering creatine kinase isoenzymes in transgenic mouse muscle by overexpression of the B subunit.
Am. J. Physiol.
264 (Cell Physiol. 33):
C151-C160,
1993
9.
Buck, M.,
and
M. Chojkier.
Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.
EMBO J.
15:
1753-1765,
1996[Medline].
10.
Caiozzo, V. J.,
F. Haddad,
M. J. Baker,
R. E. Herrick,
N. Prietto,
and
K. M. Baldwin.
Microgravity-induced transformations of myosin isoforms and contractile properties of skeletal muscle.
J. Appl. Physiol.
81:
123-132,
1996
11.
Campione, M.,
S. Ausoni,
C. Y. Guezennec,
and
S. Schiaffino.
Myosin and troponin changes in rat soleus muscle after hindlimb suspension.
J. Appl. Physiol.
74:
1156-1160,
1993
12.
Chomczynski, P.,
and
N. Sacchi.
Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
13.
Dawson, D. M.,
H. M. Eppenberger,
and
N. O. Kaplan.
Creatine kinase: evidence for a dimeric structure.
Biochem. Biophys. Res. Commun.
21:
346-353,
1965[Medline].
14.
Delday, M. I.,
and
C. A. Maltin.
Clenbuterol increases the expression of myogenin but not myoD in immobilized rat muscles.
Am. J. Physiol.
272 (Endocrinol. Metab. 35):
E941-E944,
1997
15.
Diffee, G. M.,
V. J. Ciazzo,
R. E. Herrick,
and
K. M. Baldwin.
Contractile and biochemical properties of rat soleus and plantaris after hindlimb suspension.
Am. J. Physiol.
260 (Cell Physiol. 29):
C528-C534,
1991
16.
Edgerton, W. R.,
and
R. R. Roy.
Neuromuscular adaptations to actual and simulated spaceflight.
In: Handbook of Physiology. Environmental Physiology. Bethesda, MD: Am. Physiol. Soc., 1996, sect. 4, vol. I, chapt. 32, p. 721-763.
17.
Fauteck, S. P.,
and
S. C. Kandarian.
Sensitive detection of myosin heavy chain composition in skeletal muscle under different loading conditions.
Am. J. Physiol.
268 (Cell Physiol. 37):
C419-C424,
1995
18.
Fell, R. D.,
J. M. Steffen,
and
X. J. Musacchia.
Effect of hypokinesia on rat muscle oxidative capacity and glucose uptake.
Am. J. Physiol.
249 (Regulatory Integrative Comp. Physiol. 18):
R308-R312,
1985.
19.
Gardetto, P. R.,
J. M. Schluter,
and
R. H. Fitts.
Contractile function of single muscle fibers after hindlimb suspension.
J. Appl. Physiol.
66:
2739-2749,
1989
20.
Gress, T. M.,
J. D. Hoheisel,
G. G. Lennon,
G. Zehetner,
and
H. Lehrach.
Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues.
Mamm. Genome
3:
609-619,
1992[Medline].
21.
Kandarian, S.,
S. O. Brien,
K. Thomas,
L. Schulte,
and
J. Navarro.
Regulation of skeletal muscle dihydropyridine receptor gene expression by biochemical unloading.
J. Appl. Physiol.
72:
2510-2514,
1992
22.
McCarthy, J. J.,
A. M. Fox,
L. G. Tsika,
L. Gao,
and
R. W. Tsika.
-MHC transgene expression in suspended and mechanically overloaded/suspended soleus muscle of transgenic mice.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R1552-R1561,
1997
23.
McDonald, K. S.,
C. A. Blaser,
and
R. H. Fitts.
Force-velocity and power characteristics of rat soleus muscle fibers after hindlimb suspension.
J. Appl. Physiol.
77:
1609-1616,
1994
24.
Miu, B.,
T. P. Martin,
R. R. Roy,
V. Oganov,
E. Ilyina-Kakueva,
J. F. Marini,
J. J. Léger,
S. C. Bodine-Fowler,
and
V. R. Edgerton.
Metabolic and morphologic properties of single muscle fibers in the rat after spaceflight, Cosmos 1887.
FASEB J.
4:
64-72,
1990[Abstract].
25.
Morey, E. R.
Spaceflight and bone turnover: correlation with a new rat model of weightlessness.
Bioscience
29:
168-172,
1979.
26.
Mueller, P. R.,
and
B. Wold.
In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.
Science
246:
780-785,
1989
27.
Nguyen, D.,
D. Rocha,
S. Granjeaud,
M. Baldit,
K. Bernard,
P. Naquet,
and
B. Jordan.
Differential gene expression in the murine thymus assayed by quantitative hybridization by quantitative hybridization of arrayed cDNA clones.
Genomics
29:
207-216,
1995[Medline].
28.
Ohira, Y.,
B. Jiang,
R. R. Roy,
V. Oganov,
E. Ilyina-Kakueva,
J. F. Marini,
and
V. R. Edgerton.
Rat soleus muscle fiber responses to 14 days of spaceflight and hindlimb suspension.
J. Appl. Physiol.
73:
51-57,
1992.
29.
Oishi, Y.
Relationship between myosin heavy chain IId isoform and fibre types in soleus muscle of the rat after hindlimb suspension.
Eur. J. Appl. Physiol.
66:
451-454,
1993.
30.
Pette, D.
(Editor).
Plasticity of Muscle. Proceedings of Symposium, University of Konstanz, Germany, September 23-28, 1979. Berlin: de Gruyter, 1980Pette, D. (editor). Plasticity of Muscle. Proceedings of Symposium, University of Konstanz, Germany,
September 23-28, 1979. Berlin: de Gruyter, 1980.
31.
Piétu, G.,
O. Alibert,
V. Guichard,
B. Lamy,
F. Bois,
E. Leroy,
R. M. Samson,
R. Houlgatte,
P. Soularue,
and
C. Auffray.
Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array.
Genome Res.
6:
492-503,
1996
32.
Sambrook, J.,
E. F. Fritsch,
and
T. Maniatis.
Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
33.
Schiaffino, S.,
L. Gorza,
S. Sartore,
L. Saggin,
S. Ausoni,
M. Vianello,
K. Gundersen,
and
T. Lomo.
Three myosin heavy chain isoforms in type 2 skeletal muscle fibres.
J. Muscle Res. Cell Motil.
10:
197-205,
1989[Medline].
34.
Schlegel, J.,
B. Zurbrigen,
G. Wegman,
M. Wyss,
H. M. Eppenberger,
and
T. Walliman.
Native mitochondrial creatine kinase forms octameric structures. I. Isolation of two interconvertible mitochondrial creatine kinase forms, dimeric and octameric mitochondrial creatine kinase: characterisation, localization, and structure-function relationships.
J. Biol. Chem.
263:
16942-16953,
1988
35.
Schulte, L. M.,
J. Navarro,
and
S. C. Kandarian.
Regulation of sarcoplasmic reticulum pump gene expression by hindlimb suspension.
Am. J. Physiol.
264 (Cell Physiol. 33):
C1308-C1315,
1993
36.
Takahashi, H.,
M. Wada,
and
S. Katsuta.
Expressions of myosin heavy chain IId isoform in rat soleus muscle during hindlimb suspension.
Acta Physiol. Scand.
143:
131-132,
1991[Medline].
37.
Talmadge, R. J.,
and
R. R. Roy.
Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms.
J. Appl. Physiol.
75:
2337-2340,
1993
38.
Talmadge, R. J.,
R. R. Roy,
and
V. R. Edgerton.
Distribution of myosin heavy chain isoforms in non-weight-bearing rat soleus muscles fibers.
J. Appl. Physiol.
81:
2540-2546,
1996
39.
Thomason, D. B.,
and
F. W. Booth.
Atrophy of the soleus muscle by hindlimb unweighting.
J. Appl. Physiol.
68:
1-12,
1990
40.
Tsika, R. W.,
S. D. Hauschka,
and
L. Gao.
M-creatine kinase gene expression in mechanically overloaded skeletal muscle of transgenic mice.
Am. J. Physiol.
269 (Cell Physiol. 38):
C665-C674,
1995
41.
Valenzuela, D. M.,
T. N. Stitt,
P. S. DiStefano,
E. Rojas,
K. Mattson,
D. L. Compton,
L. Nunez,
J. S. Park,
J. L. Stark,
D. R. Gies,
S. Thomas,
M. L. Beau,
A. A. Fernald,
N. G. Copeland,
N. A. Jenkins,
S. J. Burden,
D. J. Glass,
and
G. D. Yancopoulos.
Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury.
Neuron
15:
573-584,
1995[Medline].
42.
Yamashita, K.,
and
T. Yoshioka.
Profiles of creatine kinase isoenzyme compositions in single muscle fibres of different types.
J. Muscle Res. Cell Motil.
12:
37-44,
1991[Medline].
This article has been cited by other articles:
![]() |
J. ST-AMAND, K. OKAMURA, K. MATSUMOTO, S. SHIMIZU, and Y. SOGAWA Characterization of control and immobilized skeletal muscle: an overview from genetic engineering FASEB J, March 1, 2001; 15(3): 684 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chopard, F. Pons, and J.-F. Marini Cytoskeletal protein contents before and after hindlimb suspension in a fast and slow rat skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R323 - R330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schjerling, M. Hargreaves, D. Cameron-Smith, and Y. Kraniou The Importance of Internal Controls in mRNA Quantification J Appl Physiol, January 1, 2001; 90(1): 401 - 402. [Full Text] [PDF] |
||||
![]() |
S. Welle, K. Bhatt, and C. A. Thornton High-abundance mRNAs in human muscle: comparison between young and old J Appl Physiol, July 1, 2000; 89(1): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stevens, K. R. Sultan, H. Peuker, B. Gohlsch, Y. Mounier, and D. Pette Time-dependent changes in myosin heavy chain mRNA and protein isoforms in unloaded soleus muscle of rat Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1044 - C1049. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |